Concepedia

Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results

Tomasz Tykocki, R Michalik, Wiesław Bonicki, Paweł Nauman

Neurologia i Neurochirurgia Polska · 2012 · 32 citations · 11 references

DOI

Abstract

Fluorescence-guided resection of primary and recurrent MGs with 5-ALA improves control of the tumour resection. It enables the cytoreduction to be maximized but experience in neuro-oncological surgery is required to avoid serious, postoperative neurological deficits.

References

11

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21K citations · Full text

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

Walter Stummer, Uwe Pichlmeier, Thomas R. Meinel et al. · The Lancet Oncology · 2006 · 3.3K citations

, , +11

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

Michel Lacroix, Dima Abi-Said, Daryl R. Fourney et al. · Journal of neurosurgery · 2001 · 3K citations

Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients

Walter Stummer, Alexander Novotny, Herbert Stepp et al. · Journal of neurosurgery · 2000 · 863 citations

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

Edward R. Laws, Ian F. Parney, Wei Huang et al. · Journal of neurosurgery · 2003 · 660 citations